Barclays »

Seres Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $189k 135k 1.40
2023-09-30 $1.1M 461k 2.38
2023-06-30 $1.8M 371k 4.79
2023-03-31 $624k 110k 5.67
2022-12-31 $989k 177k 5.60
2022-09-30 $1.0M 158k 6.42
2022-06-30 $132k 39k 3.43
2022-03-31 $132k 19k 7.08
2021-12-31 $2.2M 262k 8.33
2021-09-30 $334k 48k 6.97
2021-06-30 $581k 24k 23.86
2021-03-31 $1.1M 55k 20.60
2020-12-31 $578k 24k 24.45
2020-09-30 $862k 30k 28.32
2020-06-30 $135k 28k 4.77
2020-03-31 $43k 12k 3.55
2019-12-31 $126k 37k 3.45
2019-09-30 $79k 20k 4.00
2019-06-30 $47k 15k 3.26
2019-03-31 $43k 6.3k 6.88
2018-12-31 $0 225 0.00
2018-09-30 $60k 7.9k 7.63
2018-06-30 $20k 2.3k 8.63
2018-03-31 $56k 7.6k 7.43
2017-12-31 $317k 31k 10.15
2017-09-30 $1.2M 75k 16.05
2017-06-30 $0 15k 0.00
2017-03-31 $388k 35k 11.10
2016-12-31 $40k 4.0k 9.95
2016-09-30 $94k 7.7k 12.24
2016-06-30 $18k 602 30.00
2016-03-31 $5.0k 202 24.75
2015-12-31 $21k 714 28.99